Efficacy of the "Living With Type 1 Diabetes to Grown-Up" Interactive Podcast Program

Launched by CHANG GUNG UNIVERSITY · Jun 13, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating a new program called "Living With Type 1 Diabetes to Grown-Up," which is an interactive podcast designed to help young people with type 1 diabetes manage their condition as they transition into adulthood. The study aims to see how effective this podcast is for individuals aged 16 to 25 who have been diagnosed with type 1 diabetes. Participants will need to have had diabetes for more than six months and have an average blood sugar level (measured by HbA1C) of 7.5% or higher in the year before joining.

To be eligible, participants must be able to communicate in Chinese or Mandarin and have a smartphone with internet access. They will also need to agree to have their voices recorded during sessions that explain the treatment process. The trial is not yet recruiting participants, and those with other serious health issues or cognitive impairments will not be included. If you're interested, it’s important to know that a parent or legal guardian will need to provide consent for participants under 18. This study could provide valuable support for young adults managing diabetes, helping them navigate their health more confidently as they grow up.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • a confirmed diagnosis of T1D by an endocrinologist before the age of 16 and a disease duration of \>6months
• • patients aged 16-25 years
• • mean HbA1C level ≥7.5% one year before inclusion
• • ability to communicate in Chinese or Mandarin
• • patients who own smartphones with internet access
• • patients who agreed to voice recording during a session explaining the treatment process
• • patients who signed the informed consent form prior to participation; for minors, a legal representative must provide consent and sign the informed consent form.
• Exclusion Criteria:
• • # T1D patients with other concomitant metabolic diseases, chromosomal aberrations, major illnesses, and cognitive impairment will be excluded from this study.